
X
Sanofi Genzyme UK medical boss Marc Moodley discusses oncology plans, NICE and Brexit
https://pharmaphorum.com/views-analysis-oncology/sanofi-genzyme-uk-medical-boss-marc-moodley-discusses-oncology-plans-nice-and-brexit/
But sales of key insulin fall amid biosimilar competition.
Tissue engineering product previously flopped in EU.